COMP <GO>
CLSK vs BAC // NET PROFIT MARGIN
CleanSpark Inc. (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: CLSK 10
— BAC 4
▲ NET PROFIT MARGIN LEADER: CLSK
LAST: $7.67 (-6.46%) • MKT CAP: $2.11B
net-margins
47.60%
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
net-margins
27.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLSK VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLSK | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.20% | 41.00% | +14.20 | CLSK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.50% | 2.50% | +12.00 | CLSK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.1x | 30.2x | -23.10 | CLSK | /valuation <GO> |
| Free Cash Flow Yield | -18.00% | 2.10% | -20.10 | BAC | /fcf-yield <GO> |
| Operating Margin | 41.60% | 32.90% | +8.70 | CLSK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 47.60% | 27.00% | +20.60 | CLSK | /net-margins <GO> |
| Revenue Growth (YoY) | 102.20% | 6.80% | +95.40 | CLSK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.46 | 0.45 | +1.01 | CLSK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | BAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 27.7 | +1.45 | CLSK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.90 | +0.03 | CLSK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.9x | 10.9x | -6.00 | CLSK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.11B | $357.61B | -$355.50B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLSK REV | BAC REV | CLSK GROSS % | BAC GROSS % | CLSK FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $766.3M | $113.10B | 55.2% | 44.0% | -$495.5M | $7.52B |
| FY 2024 | $379.0M | $105.86B | 56.3% | 44.0% | -$250.7M | -$13.57B |
| FY 2023 | $168.4M | $102.77B | 44.0% | 44.0% | -$24.8M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLSK // BETA 0.93
BAC // BETA 0.90